Therapeutic efficacy of decreased nitrite production by bezafibrate in patients with primary biliary cirrhosis

Journal of Gastroenterology

Volumn 40, Issue 2, 2005, Pages 157-163

  Akbar, Fazle ^a   Furukawa, Shinya ^a   Nakanishi, Seiji ^a   Abe, Masanori ^a   Horiike, Norio ^a   Onji, M Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bezafi brate; Dendritic cell; Nitrite; Primary biliary cirrhosis

Indexed keywords

ALKALINE PHOSPHATASE; BEZAFIBRATE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; NITRITE; URSODEOXYCHOLIC ACID;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL STRAIN; CASE REPORT; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DENDRITIC CELL; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; ENRICHMENT CULTURE; FEMALE; HUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS;

ADULT; ANTILIPEMIC AGENTS; BEZAFIBRATE; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; MIDDLE AGED; NITRITES;

EID: 15844381723     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-004-1518-3     Document Type: Article

References (18)

1. Nishio A, Bass NM, Kuketic VA, Coppel RL, Gershwin ME. Primary biliary cirrhosis: From induction to destruction. Semin Gastrointest Dis 2001;12:89-102.
2. Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, et al. Primary biliary cirrhosis: An orchestrated immune response against epithelial cells. Immunol Rev 2000; 174:210-25.
3. Jones DE. Pathogenesis of primary biliary cirrhosis. J Hepatol 2003;39:639-48.
4. Palmer JM, Kirby JA, Jones DE. The immunology of primary biliary cirrhosis: The end of the beginning? Clin Exp Immunol 2002;129:191-7.
5. Cai J, Yang J, Jones DP. Mitochondrial control of apoptosis: The role of cytochrome C. Biochim Biophys Acta 1998;1366:139-49.
6. Sanz-Cameno P, Median J, Garcia-Buey L, Garcia-Sanchez A, Borque MJ, Martin-Vilchez S, et al. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol 2002;37:723-9.
7. Hokari A, Zeniya M, Esumi H, Kawabe T, Gershwin ME, Toda G. Detection of serum nitrite and nitrate in primary biliary cirrhosis: Possible role of nitric oxide in bile duct injury. J Gastroenterol Hepatol 2002:17:308-15.
8. Battista S, Bar F, Mengozzi G, Pollet C, Torchio M, Cavalli G, et al. Evidence of an increased nitric oxide production in primary biliary cirrhosis. Am J Gastroenterol 2001;96:869-75.
9. Singh VK, Mehrotra S, Narayan P, Pandey CM, Agarwal SS. Modulation of autoimmune diseases by nitric oxide. Immunol Res 2000;22:1-19.
10. Levy C, Lindor KD. Current management of primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 2003;38: S24-37.
11. Kurihara T, Maeda A, Shigemoto M, Yamashita K, Hashimoto E. Investigation into the efficacy of bezafibrate against primary biliary cirrhosis, with histological references from cases receiving long term monotherapy. Am J Gastroenterol 2002;97:212-4.
12. Ohmoto K, Mitsui Y, Yamamoto S. Effect of bezafibrate in primary biliary cirrhosis: A pilot study. Liver 2001;21:223-4.
13. Kanda T, Yokosuka O, Imazeki F, Saisho H. Bezafibrate treatment: A new medical approach for PBC patients? J Gastroenterol 2003;38:573-8.
14. Yamamoto K, Akbar SM, Masumoto T, Onji M. Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC). Clin Exp Immunol 1998;114:94-101.
15. Sherlock S, Dooley J. Diseases of the liver and biliary system. Eleventh ed. UK: Blackwell publishing; 2002. p. 245-6.
16. Ascenzi P, Coletta M, Desideri A, Polizio F, Bertollini A, Santucci R, et al. Effect of bezafibrate and clofibric acid on the spectroscopic properties of the nitric oxide derivative of ferrous human hemoglobulin. J Inorg Biochem 1992;48:47-53.
17. Kurihara T, Niimi A, Maeda A, Shigemoto M, Yamashita K. Bezafibrate in the treatment of primary biliary cirrhosis: Comparison with ursodeoxycholic acid. Am J Gastroenterol 2000;95: 2990-2.
18. Ascenzi P, Bertollini A, Coletta M, Desideri A, Giardina B, Polizio F, et al. Cooperative effect of inositol hexakisphosphate, bezafibrate, and clofibric acid on the spectroscopic properties of the nitric oxide derivative of ferrous human hemoglobin. J Inorg Biochem 1993;50:263-72.